Clinical Trial Update: The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating vildagliptin as an adjunctive treatment for major depressive disorder was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vildagliptin (vildagliptin)

Snippet

Sponsor: Sadat City University | Conditions: Major Depressive Disorder | Phase 1, Phase 2 | Status: WITHDRAWN